Tuesday, July 28, 2026

The $1 Trillion Ransome: South Korea Must Fund Kim’s Hospitals For A Chance At Coexistence

Experts at a conference discuss shifting North Korea strategies, emphasizing long-term engagement and cooperation for peaceful coexistence.

SHADOW OF THE MUSHROOM CLOUD: Kim Jong Un’s New Tactical Nukes Target U.S. Bases For Immediate Strike

Kim Jong Un oversaw a test of a new rocket launcher, enhancing North Korea's nuclear deterrence amid U.S. defense strategy discussions.

2026 Update: North Korea’s Tactical Roads and Mines Near MDL – What You Need to Know

UNC states North Korea's border activities near the MDL don't breach the armistice, while South Korea claims they do.

Tag: Cosentyx

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion Market

Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.